Evaluation of the CIB1R peptide derived from the cytoplasmic domain of neprilysin on cell migration in an in vitro model of lung cancer - Poll - MDSpire

Evaluation of the CIB1R peptide derived from the cytoplasmic domain of neprilysin on cell migration in an in vitro model of lung cancer

  • By

  • Carlos Alejandro Martínez-Armenta

  • Horacio Almanza-Reyes

  • Leslie Patrón-Romero

  • Adriana Sampayo-Reyes

  • Juan M. Alcocer-González

  • Reyes Tamez-Guerra

  • Cristina Rodríguez-Padilla

  • Humberto Antonio Salazar-Sesatty

  • Omar Zardain-Medlich-Ducoulombier

  • Francisco González-Salazar

  • Javier Vargas-Villarreal

  • June 23, 2026

  • 0 min

Share

Original Source(s)

Evaluation of the CIB1R peptide derived from the cytoplasmic domain of neprilysin on cell migration in an in vitro model of lung cancer

  • by Carlos Alejandro Martínez-Armenta, Horacio Almanza-Reyes, Leslie Patrón-Romero, Adriana Sampayo-Reyes, Juan M. Alcocer-González, Reyes Tamez-Guerra, Cristina Rodríguez-Padilla, Humberto Antonio Salazar-Sesatty, Omar Zardain-Medlich-Ducoulombier, Francisco González-Salazar, Javier Vargas-Villarreal

  • June 23, 2026

Related Content

Impact of Financial Incentives on Electronic Health Record–Driven Recruitment of Underrepresented Communities in Research: Randomized Controlled Trial

Radiomics-based interpretable machine learning model from multiphasic CT imaging for predicting pathological grade in upper tract urothelial carcinoma: a multicenter study

MRI characteristics of cervical radioiodine-avid lymph nodes detected on post-therapeutic ¹³¹I whole-body scintigraphy in differentiated thyroid carcinoma